Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review

Abstract A systematic literature review was performed to summarize the frequency and nature of renal complications in patients with chronic hypoparathyroidism managed with conventional therapy. Methodology was consistent with the recommendations outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Peer-reviewed journal articles with specified medical subject heading terms were identified using the PubMed, EMBASE, and Cochrane databases. Data were extracted from eligible articles based on prespecified parameters for clinical outcomes of renal calcifications and disease. Because of the heterogeneity of the data, a meta-analysis could not be conducted. From 1200 potentially relevant articles, data were extracted from 13 manuscripts that reported data for ≥1 of the 19 predefined renal outcomes for ≥10 adult patients (n = 11 manuscripts) or pediatric patients (n = 2 manuscripts). The collective data provide evidence that adult and pediatric patients with chronic hypoparathyroidism and treated with conventional therapy (oral calcium and active vitamin D) had an increased risk of renal complications. The reported rate of nephrolithiasis was up to 36%, with the lowest rates in studies reporting shorter duration of disease. The rate of nephrocalcinosis was up to 38%. Some studies reported a combined nephrolithiasis/nephrocalcinosis outcome of 19% to 31%. Data for renal disease that encompassed a range of renal insufficiency to chronic kidney disease were reported in 10 articles; the reported rates ranged from 2.5% to 41%. In patients who receive long-term treatment with oral calcium and active vitamin D, chronic hypoparathyroidism may be associated with an increased risk of renal complications compared with the general population..

Medienart:	E-Artikel

Erscheinungsjahr:	2021
Erschienen:	2021

Enthalten in:	Zur Gesamtaufnahme - volume:22
Enthalten in:	Reviews in endocrine & metabolic disorders - 22(2021), 2 vom: 18. Feb., Seite 297-316

Sprache:	Englisch

Beteiligte Personen:	Gosmanova, Elvira O. [VerfasserIn] Houillier, Pascal [VerfasserIn] Rejnmark, Lars [VerfasserIn] Marelli, Claudio [VerfasserIn] Bilezikian, John P. [VerfasserIn]

Links:	Volltext [kostenfrei]

BKL:	44.89
Themen:	Chronic kidney disease Hypoparathyroidism Nephrocalcinosis Nephrolithiasis

doi:	10.1007/s11154-020-09613-1

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	SPR043921175